Mutant p97 exhibits species-specific changes of its ATPase activity and compromises the UBXD9-mediated monomerisation of p97 hexamers  by Rijal, Ramesh et al.
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a  b  s  t  r  a  c  t
p97  (VCP)  is  a homo-hexameric  triple-A  ATPase  that exerts  a plethora  of cellular  processes.  Heterozygous
missense  mutations  of p97 cause  at least  ﬁve  human  neurodegenerative  disorders.  However,  the  speciﬁc
molecular  consequences  of p97  mutations  are  hitherto  widely  unknown.  Our in  silico  structural  models  of
human and  Dictyostelium  p97  showed  that  the  disease-causing  human  R93C,  R155H,  and  R155C  as  well
as  Dictyostelium  R154C,  E219K,  R154C/E219K  p97  mutations  constitute  variations  in  surface-exposed
locations.  In-gel  ATPase  activity  measurements  of p97  monomers  and  hexamers  revealed  signiﬁcant
mutation-  and  species-speciﬁc  differences.  While  all human  p97  mutations  led to  an  increase  in ATPase
activity,  no changes  could  be detected  for the  Dictyostelium  R154C  mutant,  which  is orthologous  to
human  R155C.  The  E219K  mutation  led to an almost  complete  loss  of  activity,  which  was  partially  recu-
perated  in the  R154C/E219K  double-mutant  indicating  p97  inter-domain  communication.  By  means  of
co-immunoprecipitation  experiments  we  identiﬁed  an  UBX-domain  containing  Dictyostelium  protein  as
a novel  p97 interaction  partner.  We  categorized  all UBX-domain  containing  Dictyostelium  proteins  and
named  the interaction  partner  UBXD9.  Pull-down  assays  and  surface  plasmon  resonance  analyses  of  Dic-
tyostelium  UBXD9  or the  human  orthologue  TUG/ASPL/UBXD9  demonstrated  direct  interactions  with p97examer-monomer disassembly
as well  as  species-,  mutation-  and  ATP-dependent  differences  in  the  binding  afﬁnities.  Sucrose  density
gradient  assays  revealed  that  both  human  and  Dictyostelium  UBXD9  proteins  very  efﬁciently  disassem-
bled  wild-type,  but to  a  lesser  extent  mutant  p97  hexamers  into  monomers.  Our  results  are  consistent
with  a scenario  in  which  p97  point  mutations  lead  to  differences  in  enzymatic  activities  and  molecular
interactions,  which  in the  long-term  result  in  a late-onset  and progressive  multisystem  disease.
© 2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC. Introduction
p97, also known as VCP in Homo sapiens,  TER94 in Drosophila
elanogaster, CdcD in Dictyostelium discoideum, CDC48 in Saccha-
omyces cerevisiae,  and VAT in Thermoplasma acidophilum, is a
ery abundant and evolutionarily highly conserved member of the
riple-A (ATPase Associated with diverse cellular Activities) ATPase
amily (Halawani and Latterich, 2006; Madsen et al., 2009). This
g2+-dependent ATPase has a tripartite structure comprising an
-terminal CDC48 domain followed by the D1 and D2 domains that
∗ Corresponding authors.
E-mail addresses: christoph.clemen@uni-koeln.de (C.S. Clemen),
udwig.eichinger@uni-koeln.de (L. Eichinger).
1 Co-senior authors.
ttp://dx.doi.org/10.1016/j.ejcb.2016.03.004
171-9335/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
bind and hydrolyse ATP (Chou et al., 2014; DeLaBarre and Brunger,
2003). p97 assembles into a ring shaped hexameric complex of six
identical subunits where the D domains form the central cylinder
surrounded by the CDC48 domains (Rouiller et al., 2002; Zhang
et al., 2000). The energy derived from ATP hydrolysis changes the
p97 hexameric structure and is utilized to regulate cofactor bind-
ing and associated activities (Beuron et al., 2006). p97 is involved in
a plethora of cellular processes such as membrane dynamics, pro-
tein quality control, cell cycle, apoptosis, and DNA damage response
(Baek et al., 2013; Meyer and Weihl, 2014).
Until 2011, twenty heterozygous missense mutations had been
described in human p97 with codon 155 being a mutation hot
spot (Nalbandian et al., 2011). To date, the number of p97 gene
mutations has markedly risen, leading to 41 different missense
mutations (215th ENMC International Workshop on IBMPFD, in
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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ress). Initially, it was shown that p97 mutations cause the
ate-onset and slowly progressive multi-system disorder IBMPFD
Inclusion Body Myopathy associated with Paget disease of bone
nd Fronto-temporal Dementia) (Watts et al., 2004). Meanwhile,
our more neurodegenerative disorders, ALS (Amyotropic Lateral
clerosis) (Johnson et al., 2010), Parkinson’s disease (Chan et al.,
012), HSP (Hereditary Spastic Paraplegia) (de Bot et al., 2012),
nd Charcot-Marie-Tooth disease type 2 (HMSN2) (Gonzalez et al.,
014) have been attributed to p97 missense mutations. The exact
olecular mechanisms by which p97 mutations cause these late-
nset disorders remain elusive. However, an increasing number
f reports showed mutation-speciﬁc effects on p97 interaction
artners with functional consequences on endocytosis (Ritz et al.,
011), endoplasmic reticulum associated degradation (ERAD) of
roteins (Erzurumlu et al., 2013), ATPase activity (Zhang et al.,
015), or 20S proteasome binding (Barthelme et al., 2015).
Regulation of p97 functions is mediated by many cofactors of
hich UBX (ubiquitin regulatory X) domain containing proteins
onstitute the largest subgroup (Kloppsteck et al., 2012; Schuberth
nd Buchberger, 2008). The UBX domain is an evolutionarily con-
erved 80 amino acids region that shares structural similarity with
biquitin (Buchberger et al., 2001). Mammalian TUG (Tether con-
aining a UBX domain for GLUT4) (Bogan et al., 2003), which is also
nown as ASPL (alveolar soft part sarcoma locus) (Madsen et al.,
014) or UBXD9 (Meyer and Weihl, 2014), is a member of this fam-
ly and involved in insulin stimulated redistribution of the glucose
ransporter GLUT4 (Bogan et al., 2003) and the assembly of the Golgi
omplex (Orme and Bogan, 2012).
In this study, we identiﬁed an orthologous, uncharacterized Dic-
yostelium UBX domain containing protein as a novel p97 binding
artner, which we accordingly named UBXD9. We  assessed func-
ional consequences of human and Dictyostelium p97 mutations on
heir ATPase activities and UBXD9 interactions. We  demonstrated
hat disease-causing p97 mutations enhance the ATPase activity
f human p97 and impede the UBXD9-mediated disassembly of
uman and Dictyostelium p97 hexamers to monomers.
. Materials and methods
.1. Protein sequence and domain analyses
Sequence stretches of H. sapiens (UniProt ID: P55072), Mus
usculus (Q01853), Danio rerio (Q7ZU99), Caenorhabditis ele-
ans (P54812), D. discoideum (DDB G0288065), and S. cerevisiae
P25694) p97 were aligned using ClustalW2 (http://www.ebi.ac.
k/Tools/msa/clustalw2/). Similarly, UBXD9 protein sequences of
. sapiens (TUG/ASPL, Q9BZE9), M.  musculus (TUG, Q8VBT9), D.
erio (TUG, Q568S9), C. elegans (TUG, Q17425), D. discoideum
UBXD9, DDB G0279285), and S. cerevisiae (UBX4, P54730) were
erived from UniProtKB (http://www.uniprot.org/) and dictyBase
http://www.dictybase.org/) and used for domain analysis using
MART (http://smart.embl-heidelberg.de/) and CDD (http://www.
cbi.nlm.nih.gov/Structure/cdd/cdd.shtml). Orthologous pairs of
uman and Dictyostelium UBXD proteins were determined by
orward and reverse BLAST (http://blast.ncbi.nlm.nih.gov/Blast.
gi) analyses. Transmembrane domains were predicted using
MHMM  (http://www.cbs.dtu.dk/services/TMHMM/). Structure-
ased amino acid sequence alignments were generated with SBAL
Wang et al., 2012) based on predictions of secondary structure
lements with PSIPRED (Bryson et al., 2005)..2. Molecular modelling
Based on the crystal structure of mouse p97 (PDB entry 3cf2
avies et al., 2008), the human p97 protein sequence, and all Biology 95 (2016) 195–207
combination of manual modelling, geometry optimization and
molecular dynamics simulation, we have constructed a full-length
model of human p97 (residues 21-766 of the 806 residue protein).
Using this human p97 model as a template the three-dimensional
model of D. discoideum p97 was generated by comparative mod-
elling with the software MODELLER (Sali and Blundell, 1993). In
brief, an amino acid sequence alignment of the human and D.
discoideum protein sequences was  performed with SBAL (Wang
et al., 2012) and then subjected to the routine ‘automodel’ in MOD-
ELLER 9v7. 100 individual models were calculated from which the
model with the lowest objective function (5118.6; next lowest
was 5173.1) was  chosen. Subsequently, the D. discoideum p97 hex-
amer was  assembled by superimposing the D. discoideum monomer
onto each monomer of the re-constructed hexameric p97 from PDB
entry 3cf2 using the software COOT (Emsley and Cowtan, 2004).
2.3. Vector construction
Vectors for the expression of wild-type and mutant human GST-
p97 (Hübbers et al., 2007) and for the expression of wild-type and
mutant Dictyostelium GST-p97 and p97-RFP (Arhzaouy et al., 2012)
were previously described. For expression of human GST-UBXD9
the plasmid EX-W1107-B03 (GeneCopoeia) was used. The coding
sequence of Dictyostelium UBXD9 was  ampliﬁed by PCR from AX2
cDNA and cloned into the pGEX-6P-1 bacterial expression vector
(GE Healthcare). Likewise, the UBX domain comprising amino acids
384–466 of Dictyostelium UBXD9 was cloned and expressed for the
generation of Dictyostelium UBXD9-speciﬁc rabbit polyclonal anti-
bodies (pAbs). For ectopic expression of UBXD9-GFP or GFP-UBXD9
in Dictyostelium cells, the UBXD9 cDNA was  cloned into the BamHI
and XmaI restriction sites of pBsr-C-GFP-C1 and pBsr-N-GFP-N2
expression plasmids (Blau-Wasser et al., 2009), respectively. The
expressed UBXD9 GFP-fusion proteins each contained a linker of
six amino acids (GGSGGS). The inserts of all expression plasmids for
human and Dictyostelium p97 and UBXD9 were veriﬁed by sequenc-
ing.
2.4. Dictyostelium strains and transformation
All Dictyostelium strains were grown at 21 ◦C in liquid nutri-
ent AX2 medium (for 1 l: 14.3 g bacteriological peptone, 7.15 g
yeast extract, 18 g maltose, 0.62 g Na2HPO4 × 2H2O, 0.49 g KH2PO4,
pH 6.7) on 100 mm diameter plates or in shaking culture at
160 rpm (Brink et al., 1990) or on a lawn of Klebsiella aerogenes
on SM agar plates (Williams and Newell, 1976). Expression plas-
mids were transformed into wild-type Dictyostelium AX2 cells
by electroporation (Gaudet et al., 2007) and transformants were
selected using 5 g/ml BlasticidinS or 6 g/ml G418. Stable trans-
formants expressing GFP-UBXD9 or UBXD9-GFP were selected by
ﬂuorescence microscopy and visual inspection, and expression
was veriﬁed by Western blotting using UBXD9-speciﬁc polyclonal
antibodies UBX23519 or UBX23520 (see below) and anti-GFP anti-
bodies. Similarly, strains expressing wild-type and mutant p97-RFP
variants were veriﬁed by anti-RFP and anti-p97 immunoblotting.
Strains expressing similar amounts of the endogenous and the cor-
responding fusion protein were selected for further experiments.
2.5. Puriﬁcation of recombinant Dictyostelium and human p97
and UBXD9
Wild-type and mutant Dictyostelium GST-p97 and GST-UBXD9
fusion proteins were expressed in Escherichia coli XL1 Blue (New
England Biolabs), wild-type and mutant human GST-p97 in E. coli
Arctic express RIL (Stratagene), and human GST-UBXD9 in BL21
Gold (DE3) pLysS (Stratagene) cells. Cells were grown in 30 ml
LB medium containing 50 g/ml ampicillin for E. coli XL1 Blue,
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0 g/ml ampicillin and 20 g/ml gentamycin for Arctic express
IL, and 50 g/ml ampicillin and 50 g/ml chloramphenicol for
L21 Gold (DE3) pLysS cells at 37 ◦C overnight. 500 ml  fresh LB
edium without antibiotics were inoculated with 1% overnight
ulture and grown at 37 ◦C until an OD600 of 0.6–0.7 followed by
nduction with 1 mM IPTG overnight at 21 ◦C for XL1 Blue and
L21 Gold (DE3) pLysS cells or at 10 ◦C for Arctic express RIL cells.
ells were harvested at 15,000g for 10 min  at 4 ◦C, resuspended
n 20 ml  lysis buffer (25 mM Tris/HCl, pH 7.4, 5 mM EDTA, 0.1%
riton X-100, 10% glycerol, 150 mM NaCl, 1:50 protease inhibitor
ocktail (Sigma)) and opened using an Avestin Emulsiﬂex C3 high
ressure homogenizer (Avestin). The cell homogenates were cen-
rifuged at 20,000g for 20 min  at 4 ◦C, and 300 l of washed
lutathione sepharose 4B beads (GE Healthcare) were added to
he supernatants followed by incubation under shaking for 3 h at
◦C. GST-fusion proteins bound beads were pelleted at 500g for
0 s, washed 5 times with protease cleavage buffer (1x PBS with
 mM DTT), and incubated overnight with PreScission protease (GE
ealthcare) on a rotating wheel at 4 ◦C. Beads were centrifuged
t 500g for 10 s and soluble proteins were collected. For qual-
ty control, aliquots of the puriﬁed proteins were fractionated by
DS-PAGE and stained by Coomassie Brilliant blue. Protein concen-
rations were determined by a Bradford assay.
.6. Antibodies, immunoblotting, and protein quantitation
For generation of Dictyostelium UBXD9-speciﬁc polyclonal anti-
odies (pAbs) the GST-tag was proteolytically removed from the
ecombinant UBX construct and the puriﬁed UBX domain was used
or immunization of rabbits (BioGenes). Resulting sera from rab-
its UBX23519 and UBX23520 were diluted 1:10,000 for Western
lot tests using total proteins from 2 × 105 AX2 cells. GFP was
etected with mouse monoclonal antibody K3-184-2 at a 1:50
ilution (Noegel et al., 2004), RFP with a rabbit polyclonal anti-
ody at 1:10,000 (mCherry pAb, Wiesner et al., 2010), actin with
he monoclonal Act1-7 antibody at 1:50 (Simpson et al., 1984),
uman and Dictyostelium p97 with rabbit polyclonal p97 8 6841 at
:10,000 (Arhzaouy et al., 2012), and human UBXD9 with a rabbit
olyclonal antibody at 1:1,000 (#2049, Cell Signaling). Secondary
ntibodies used were anti-rabbit and anti-mouse IgG conjugated
ith peroxidase (Sigma). Detection was done by chemilumines-
ence in conjunction with the Fluorchem SP imaging system (Alpha
nnotech); the Spot Denso tool of the AlphaEaseFC software (Alpha
nnotech) was used for densitometry analyses.
.7. Clear-native PAGE and in-gel ATPase assay
Clear-native PAGE (CN-PAGE) was performed as described
Wittig and Schägger, 2008) and used to analyse the oligomeric
tates of wild-type and mutant p97 proteins. Brieﬂy, p97 pro-
eins were expressed and puriﬁed as described above. Proteins
ere mixed with 3x native PAGE sample buffer (60 mM Bis-Tris,
.5 M 6-aminocaproic acid, 60 mM NaCl, 30% glycerol) and sepa-
ated on an acrylamide gel gradient (5–15% acrylamide, 500 mM
-aminocaproic acid, pH 7.0, 50 mM Bis-Tris, pH 7.0, 0.05% APS,
.05% TEMED) that was prepared using a peristaltic pump and a
tacking gel (4% acrylamide, 500 mM 6-aminocaproic acid, pH 7.0,
0 mM Bis-Tris, pH 7.0, 0.08% APS, 0.2% TEMED). Gels were run
n cathode buffer (50 mM Tricine, 15 mM Bis-Tris, 0.05% sodium
eoxycholate, 0.02% n-dodecyl-ß-D-maltoside, pH 7.0) and anode
uffer (50 mM Bis-Tris, pH 7.0) at 150 V for 4 h at 4 ◦C. NativeMark
rotein standard (Invitrogen) was used to estimate the molecular
ass of the protein complexes.
The in-gel ATPase activity assay was performed as described
Zerbetto et al., 1997). Prior to the assay the amounts of wild-
ype and mutant p97 hexamers were estimated by Coomassiell Biology 95 (2016) 195–207 197
Brilliant blue stained CN-PAGE gels. Approximately equal amounts
of hexamers were then separated by CN-PAGE and the gels were
incubated under slight shaking at room temperature overnight in
freshly prepared ATPase activity buffer 50 mM Tris/270 mM glycine
solution pH 8.2, 14 mM MgSO4, 8 mM ATP, 0.1% Pb(NO3)2 (note:
Pb(NO3)2 is highly toxic; for optimal solubility the pH value of the
ﬁnal buffer is critical). The ATPase activities were visible as white
bands of Pb3(PO4)2 precipitates formed by the reaction between
Pb(NO3)2 and the PO4 produced by the ATP hydrolysis. For quan-
titation, gels were scanned on a black background. Next, the white
precipitates were removed by overnight incubation in acid ﬁxa-
tion solution (50% methanol, 10% acetic acid) followed by staining
with Coomassie Brilliant blue and scanning for quantitation of p97
hexamer amounts.
2.8. Co-immunoprecipitation and pull-down assays
For co-immunoprecipitation experiments Dictyostelium cells
ectopically expressing p97WT-RFP were grown at 21 ◦C in 100 ml
AX2 medium containing 5 g/ml BlasticidinS. Log-phase cells
(2–4 × 106 cells/ml) were harvested by centrifugation for 5 min
at 500g and lysed in 25 ml  lysis buffer (30 mM HEPES, pH 7.5,
100 mM NaCl, 5 mM MgCl2, 2 mM ATP, 1 mM DTT, 0.5% Triton
X-100, 1 mM PMSF, protease inhibitor cocktail (Roche)). Homog-
enization was  done by 20 strokes of a tightly ﬁtting Dounce
homogenizer (Wheaton). Cell homogenates were centrifuged for
20 min  at 15,000g to spin down the cell debris and supernatants
were pre-cleared with 100 l protein A sepharose beads for 1 h at
4 ◦C. Another 100 l protein A sepharose beads in PBS were incu-
bated with 7 l rabbit polyclonal anti-RFP serum for 2 h at 4 ◦C,
collected by centrifugation at 500g for 10 s, and blocked overnight
with 5% BSA in PBS on a rotating wheel at 4 ◦C; control beads were
only incubated with BSA. The pre-cleared supernatants (7 ml)  were
incubated with either the antibody bound or the control beads for
90 min  at 4 ◦C. Beads were spun down, washed two times with
lysis buffer and ﬁve times with washing buffer (lysis buffer without
protease inhibitor cocktail). Finally, beads were boiled for 5 min  in
100 l SDS sample buffer, and proteins were separated by 10% SDS-
PAGE gels and stained with Imperial Protein Stain (Thermo-Fisher
Scientiﬁc). Proteins bands were excised and proteins identiﬁed
by tandem mass spectrometry (LC–MS/MS) as described (Clemen
et al., 2010).
Pull-down assays were performed using the recombinant puri-
ﬁed proteins. Wild-type or mutant Dictyostelium or human p97 was
added to Dictyostelium or human GST-UBXD9 coated glutathione-
beads and incubated in a ﬁnal volume of 50 l PBS supplemented
with 1 mM  DTT on a rotating wheel for 3 h at 4 ◦C. For the inverse
pull-down experiments Dictyostelium or human UBXD9 was added
to wild-type or mutant Dictyostelium or human GST-p97. Beads
were collected by centrifugation, supernatants were kept and the
beads washed ﬁve times with 150 l PBS/DTT. 30 l of the super-
natants were mixed with 15 l 3x SDS sample buffer, and the beads
with 45 l 1x SDS sample buffer. Supernatant and pellet fractions
were analysed by Ponceau S and Coomassie Brilliant blue stains as
well as immunoblotting.
2.9. Surface plasmon resonance
Surface plasmon resonance (SPR) measurements were per-
formed using a Biacore 3000 (Biacore) system. The surface of a
CM5  sensor chip (GE Healthcare) was  activated by injection of
a 1:1 mixture of 0.1 M N-hydroxysuccinimide (NHS) and 0.4 M
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDS). Dictyostelium or human UBXD9 was  diluted to 20 g/ml in
10 mM sodium acetate, pH 4.5, injected into one of the four ﬂow
cells and immobilized on the activated chip surface using amine-
198 R. Rijal et al. / European Journal of Cell Biology 95 (2016) 195–207
Fig. 1. Domain organization and structural information of Dictyostelium p97.
A.  Domain organization of Dictyostelium p97. The N-terminal region comprising the CDC48 N and CDC48 2 domains (light blue) is followed by the D1 and D2 domains
(blue  and purple, respectively) and the C-terminal extension (grey). Domain structure was analysed using SMART (http://smart.embl-heidelberg.de/). B. Multiple sequence
alignments of selected p97 N-terminal sequence stretches of H. sapiens, M. musculus, D. rerio, C. elegans, D. discoideum and S. cerevisiae. The highly conserved R92, R154, and
E219  amino acids that were investigated in this study are highlighted. Dictyostelium R92 and R154 are orthologous to human R93 and R155. Multiple sequence alignments
were  prepared using ClustalW. Asterisks represent absolutely conserved residues; colons and periods represent conserved residues of strongly similar properties (score > 0.5)
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f  a Dictyostelium p97 hexamer. The N domains are coloured light blue, the D1 do
92,  R154 and E219 are indicated in red; in the hexamer, residue positions are only
oupling. HBS-EP (0.01 M HEPES, 150 mM NaCl, 3 mM EDTA, 0.005%
olysorbate 20; pH 7.4) was used as the circulating buffer for
he immobilization. The remaining non-reacted ester groups were
uenched with 1 M ethanolamine, pH 8.5. The amounts of immobi-
ized Dictyostelium and human UBXD9 were approximately 1,500
U. A second ﬂow cell was activated by injection of NHS and EDC,
mmediately quenched with ethanolamine, and used as reference
ow cell.
For kinetic studies, circulating buffer was changed to 1x PBS
upplemented with 1 mM DTT and 0.005% Tween 20. Association
2 min) and dissociation (10 min) of varying concentrations of Dic-
yostelium or human wild-type or mutant p97 (5 nM to 160 nM)
ere monitored at 25 ◦C and a 30 l/min ﬂow rate. Base lines
ere achieved after the removal of bound p97 by a 90 s injection
f 10 mM glycine pH 1.7 at a 30 l/min ﬂow rate. The response
bserved in the reference ﬂow cell served as an in-line control
nd was subtracted for each sensorgram to correct for non-speciﬁc
inding. A run of circulating buffer alone in the two  ﬂow cells
as subtracted from the speciﬁc binding sensorgrams to minimize
nstrument noise. Kinetic parameters were analysed by globally ﬁt-
ing the various concentrations of p97 to the 1:1 Langmuir model
sing the BIAevaluation software (version 4.1).
.10. Fluorescence microscopy
Dictyostelium cells were grown axenically on culture plates, non-
dherent, dead cells were removed, and cells were detached from
he surface using fresh Sørensen buffer. Coverslips of 12 mm Ø were
ither ﬁxed with silica gel to the bottom of a 100 mm Ø petri dish or
ut in 24 well plates. 3.5 × 105cells were allowed to adhere to each
2 mm coverslip by incubating for 30 min  at room temperature. The
uffer was removed and cells were ﬁxed by addition of −20 ◦C cold. Cartoon representation of a Dictyostelium p97 monomer. D. Surface representation
 blue, the D2 domains purple, and the C-terminal extension grey. The positions of
led for a single monomer. Structures were prepared with PyMOL (DeLano, 2002).
methanol and further incubated for 5 min  at −20 ◦C. The coverslips
were washed 3 times for 5 min with 200 l PTB buffer (1x PBS, 0.1%
Triton X-100, 0.1% BSA). Fixed cells were incubated overnight at 4 ◦C
with primary antibodies diluted in PTB buffer; UBX23519, 1:100;
UBX23520, 1:100; p97 8 6841, 1:100. Then cells were washed 3
times with PTB buffer for 5 min  each, and incubated with the
appropriate secondary antibody, Alexa-ﬂuor 488 goat anti-rabbit,
1:1,000 or Alexa-ﬂuor 568 goat anti-rabbit, 1:1,000 (Invitrogen),
diluted in PTB buffer. Nuclei were stained with 4′,6-diamidino-2-
phenylindole (DAPI) at a ﬁnal concentration of 0.5 g/ml in PTB
buffer for 1 h at room temperature in the dark. Finally, the cov-
erslips were washed 3 times for 5 min  with 200 l PTB, 1 time
with 1x PBS, 1 time with ddH2O for 5 min, and embedded in Gel-
vatol. Images were acquired using a Leica DMI6000B microscope
with a 100x HC Pl APO 1.4 oil immersion objective equipped with
the Quorum Ångström structured illumination technique (Optigrid
module) and the Leica MM-AF software (v.1.3.0).
2.11. Sucrose density gradient sedimentation assay
To analyse the oligomeric state of wild-type and mutant Dic-
tyostelium and human p97 in the presence or absence of UBXD9,
sucrose density gradient sedimentation was  performed adapted
from (Orme and Bogan, 2012). Gradients were prepared in 13.5 ml
ultra-clear centrifugation tubes (Beckman Coulter) by layering
1 ml  volumes of sucrose in gradient buffer (20 mM Hepes, pH
7.4, 150 mM KCl, 1 mM MgCl2). The concentrations of sucrose
were successively decreased from 1.1 M at the bottom to 0.3 M
at the top in 0.1 M steps. Wild-type or mutant Dictyostelium or
human p97 was incubated with and without Dictyostelium or
human UBXD9 in equimolar ratios without ATP for 30 min  prior to
sedimentation. Samples were loaded onto the gradients and cen-
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Fig. 2. In-gel ATPase activity of recombinant human and Dictyostelium wild-type
and mutant p97 proteins.
A. Proteins were subjected to 5–15% gradient CN-PAGE. Upper panel, gel part con-
taining p97 hexamers at approximately 600 kDa; lower panel, part from the same
gel with p97 monomers at approximately 100 kDa. Upper rows, in-gel ATPase activ-
ity  stain based on the formation of white precipitates of lead phosphate; lower
rows, subsequent Coomassie Brilliant blue (CBB) staining. B. Quantitative analysis
showing the ATPase activities of human (light grey) and Dictyostelium (dark grey)R. Rijal et al. / European Journa
rifuged at 120,000g in a SW41 Ti (III) rotor (Beckman Coulter)
or 16 h at 4 ◦C. Fractions of 0.5 ml  were collected from the top of
he gradient. From each fraction 50 l samples were taken, mixed
ith 25 l 3x SDS sample buffer, and analysed by SDS-PAGE and
oomassie Brilliant blue staining.
. Results
.1. Domain structure and homology model of Dictyostelium p97
The highly conserved triple-A ATPase p97 is composed of the N-
erminal CDC48 domain, the two ATPase domains D1 and D2, and
 non-classiﬁed C-terminal region (Fig. 1A). From the reported 41
uman p97 point mutations (215th ENMC International Workshop
n IBMPFD, in press), we selected R155C and R155H, the two  most
requently reported p97 mutations, and R93C for further analyses.
or these three mutations we previously studied the IBMPFD skele-
al muscle pathology (Hübbers et al., 2007). For Dictyostelium p97,
e included in this study the R154C mutation (Arhzaouy et al.,
012), which is orthologous to human R155C p97. Furthermore,
e analysed the Dictyostelium R154C/E219K double-mutant p97,
hich was accidentally created in our p97 in vitro mutagenesis.
or comparative analysis we generated the E219K single mutant
97, although this mutation has so far not been described to cause
isease. Alignments of sequence stretches bordering the mutated
esidues showed that these regions are highly conserved from yeast
o man  (Fig. 1B).
Human and Dictyostelium p97 share 81% identity and 89% simi-
arity on the amino acid sequence level and have an almost identical
rder and composition of secondary structure elements (Fig. S1). As
o crystal structure of Dictyostelium p97 is available, we  used the
ouse p97 structure (PDB entry 3cf2 Davies et al., 2008), which pos-
esses the most extended coverage, for the generation of full-length
uman and Dictyostelium p97 homology models. First, we used
 combination of manual modelling, geometry optimization and
olecular dynamics simulations to construct the human p97 model
ased on the mouse crystal structure and the human sequence
Genbank entry AAI10914). In a second step, the human model
nd the Dictyostelium sequence (DDB G0288065) served to gen-
rate a structural model of Dictyostelium p97 (Fig. 1C). Finally, the
ictyostelium p97 hexamer was assembled by superimposing the
btained monomer structure onto each monomer of the mouse
97 hexamer. Our three-dimensional models of Dictyostelium and
uman p97 showed that the investigated mutated amino acids are
ll located on the surface of p97 and thus are accessible for inter-
ction partners (Fig. 1D).
.2. In-gel p97 ATPase activity measurements reveal signiﬁcant
utation- and species-speciﬁc differences
We  analysed and compared the ATPase activities of human
nd Dictyostelium wild-type and mutant p97 proteins. Though
he ATPase activity is crucial for p97 functions, effects of muta-
ions are still a matter of debate. This may  be attributed to the
ethodology of a conventional ATPase assay in solution, where
he results may  be inﬂuenced by degradation products or contami-
ations from protein puriﬁcation. To circumvent these problems
e established an in-gel ATPase activity stain approach after
lear-native polyacrylamide gel electrophoresis (CN-PAGE). We
ubjected recombinant human p97WT, p97R155C, p97R155H, and
97R93C as well as Dictyostelium p97WT, p97R154C, p97E219K, and
97R154C/E219K to CN-PAGE followed by the ATPase activity assay
nd ﬁnally Coomassie Brilliant blue stains. Notably, all missense
utations of human p97 caused a marked increase in the ATPase
ctivity of p97 hexamers as compared to the wild-type protein.wild-type and mutant p97 hexamers after normalization to the protein content with
human p97WT scaled to 1. Bars show mean values and standard deviations of 3–7
independent experiments; p-values were calculated by Student’s t-test.
Moreover, we  also observed weak ATPase activity at the position of
p97R155C monomers (Fig. 2A). Quantitation and normalization by
densitometry analysis of the ATPase and Coomassie Brilliant blue
intensities revealed an approximately four-fold increase in ATPase
activity of the human p97 mutations (Fig. 2B, grey bars). In contrast,
we did not observe an increase in the ATPase activity of the orthol-
ogous Dictyostelium p97R154C mutant as compared to p97WT. Our
additional E219K mutation, although not located within the D1-
domain, led to an almost complete loss of ATPase activity, which
was partially recuperated in the p97R154C/E219K double-mutant
(Fig. 2B, black bars). A comparison of the ATPase activities of human
and Dictyostelium wild-type p97 hexamers showed that the ATPase
activity of wild-type Dictyostelium p97 was considerably higher
than that of the human orthologue. Thus, despite high structural
conservation human and Dictyostelium p97 proteins differed sig-
niﬁcantly in mutation-induced changes as well as in their basal
ATPase activities.
3.3. Dictyostelium and human UBXD9 proteins directly interact
with p97
We performed co-immunoprecipitation experiments using
total cell lysates from Dictyostelium cells ectopically expressing
200 R. Rijal et al. / European Journal of Cell Biology 95 (2016) 195–207
Fig. 3. Dictyostelium and human UBXD9 orthologues directly interact with p97.
A.  For co-immunoprecipitation experiments total cell lysate from AX2/p97WT-RFP cells was  used (input). RFP antibodies co-precipitated p97WT-RFP and endogenous p97
together with UBXD9 (IP). Protein bands were excised and subjected to mass spectrometry analyses. Asterisk, degradation product of p97WT-RFP. B. Domain organization of
UBXD9 orthologues from H. sapiens (Hs), M.  musculus (Mm), D. rerio (Dr), C. elegans (Ce), D. discoideum (Dd) and S. cerevisiae (Sc). The TUG-UBL1 domains are coloured dark
grey,  the coiled coil domains green, and the UBX domains blue. Protein domains were predicted using SMART (http://smart.embl-heidelberg.de/) and CDD (http://www.
ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml). Although both domain prediction programs did neither predict an UBX domain nor a correctly positioned coiled coil domain for
C.  elegans UBXD9 and no coiled coil domains for D. rerio UBXD9 and S. cerevisiae UBXD9 (UBX4), manual sequence alignments with human UBXD9 revealed the presence
of  these domains in all cases (hatched blue and hatched green). A further secondary structure-based alignment of the UBXD9 proteins conﬁrmed the existence of -helices
in  the predicted coiled coil domains (data not shown). Numbers indicate amino acid positions. C. Pulldown assay using recombinant Dictyostelium GST-UBXD9 coupled
to  glutathione beads or GST for control together with recombinant Dictyostelium non-tagged wild-type or mutant p97 (inputs). Upper panels, Ponceau S staining; lower
panels,  p97 immunoblotting. UBXD9 pulled down very efﬁciently wild-type p97 (P) with no protein visible in the supernatant (S) and, to a slightly lesser extent p97R154C,
p97E219K, and p97R154C/E219K. In the controls wild-type and mutant p97 was only detected in the supernatant. Distance labels indicate p97 degradation products. D. Pulldown
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2ssay  using recombinant human GST-UBXD9 or GST for control coupled to glutathi
97R93C (inputs). Panels show Coomassie stained gels. GST-UBXD9 pulled down ver
,  GST-UBXD9; 2, p97; 3, degradation product of UBXD9. In the control p97 was pre
97WT-RFP (Arhzaouy et al., 2012). This resulted in the co-
recipitation and mass spectrometry-based identiﬁcation of an
ncharacterized UBX domain containing (UBXD) protein (Fig. 3A).
equence analyses showed that this protein with an appar-
nt molecular mass of 95 kDa is one of 11 UBXD proteins in
ictyostelium.  Similarity searches further revealed that the Dic-
yostelium protein is the orthologue of the human TUG (Tether
ontaining UBX domain for GLUT4) protein (Bogan et al., 2003), also
nown as ASPL (Madsen et al., 2014) or UBXD9 (Meyer and Weihl,
014), which is one out of 13 members of the human UBXD pro-ads together with recombinant human non-tagged p97WT, p97R155C, p97R155H, and
iently wild-type and mutant p97 (P) with no protein visible in the supernatant (S).
nantly present in the supernatant.
teins (Meyer and Weihl, 2014). Since none of the 11 Dictyostelium
UBXD proteins had been characterized so far, we  categorized
these proteins based on sequence comparisons with the 13 human
UBXD proteins and found that only ﬁve of the Dictyostelium and
human UBXD proteins were clear orthologues (Table 1). In view of
inconsistent naming and consecutive numbering of UBXD proteins
in e.g., human, yeast and plants, we propose a naming scheme
that completes the human numbering with addition of UBXD10,
11, and 13, and extends the consecutive UBXD protein number-
ing with the non-orthologous Dictyostelium UBXD proteins 14–19.
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Table  1
Categorization and proposed naming scheme of the 13 human and 11 Dictyostelium UBX domain containing (UBXD) proteins. The naming scheme completes the human
numbering with addition of UBXD10, 11, and 13, and extends the consecutive UBXD protein numbering with the non-orthologous Dictyostelium UBXD proteins 14–19. Based
on  size, sequence similarity and domain structure ﬁve of the human and Dictyostelium UBXD proteins are clear orthologues.
Dictyostelium discoideum Homo sapiens homology scores
dictyBase ID proposed protein
name
aa protein name UniProt ID HUGO gene name aa % identity to
human protein
% similarity to
human protein
% coverage of
Dicty protein
UBXD1 Q9BZV1 UBXN6 441
UBXD2 (Erasin) Q92575 UBXN4 508
UBXD3 Q96LJ8 UBXN10 280
UBXD4 P68543 UBXN2A 259
UBXD5 (Socius;COA-1) Q5T124 UBXN11 520
DDB G0269774 UBXD6 264 UBXD6 (Rep-8) O00124 UBXN8 270 28 56 30b
DDB G0270358 UBXD7 503 UBXD7 O94888 UBXN7 489 28 48 97
DDB  G0280423 UBXD8 362 UBXD8 Q96CS3 FAF2 445 29 52 83
DDB  G0279285 UBXD9 573 UBXD9 (TUG;ASPL) Q9BZE9 ASPSCR1 553 28 51 50c
DDB G0293498 UBXD10 415 UBXD10a (p47) Q9UNZ2 NSFL1C 370 33 52 99
UBXD11a (p37) Q14CS0 UBXN2B 331
UBXD12 Q9UNN5 FAF1 650
UBXD13a (SAKS1) Q04323 UBXN1 297
DDB  G0289369 UBXD14 420
DDB G0268260 UBXD15 391
DDB G0291259 UBXD16 543
DDB G0268746 UBXD17 409
DDB G0276057 UBXD18 540
DDB G0274349 UBXD19 662
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b The human and Dictyostelium UBXD6 harbour in addition to the C-terminal UBX
c Human and Dictyostelium UBXD9 proteins are similar in size and have the same
he proposed numbering scheme has the advantage that nam-
ng of orthologues with the same number will be straightforward
nd allows for extension by further non-orthologous UBXD fam-
ly members from other organisms. Accordingly, we  named the
dentiﬁed Dictyostelium UBX domain containing protein as UBXD9
Table 1). UBXD9 proteins contain the conserved TUG-UBL1 domain
f approximately 60 amino acids at the N-terminus and an 80
mino acids UBX domain in the C-terminal part. Furthermore, our
equence analyses revealed that all members harbour in addition
 coiled coil domain preceding the UBX domain (Fig. 3B).
In a next step, we ﬁrst performed pull-down assays to verify
he Dictyostelium p97–UBXD9 protein interaction and to address
otential effects of point mutations in p97. We  analysed the
nteraction of recombinant GST-UBXD9 with Dictyostelium p97WT,
97R154C, p97E219K and p97R154C/E219K (Fig. 3C). We  conﬁrmed that
97 and UBXD9 interacted directly. GST-UBXD9 completely pulled
own wild-type p97 into the pellet fraction. Moreover, we found
hat all point mutated p97 variants also interacted, albeit not as
trongly as wild-type p97 with some protein remaining in the
upernatant fraction. In control experiments using GST instead of
ST-UBXD9, all p97 variants exclusively remained in the super-
atant. Vice versa we used GST-p97WT, −p97R154C, −p97E219K and
p97R154C/E219K to pull down non-tagged UBXD9. Here, UBXD9
nteracted to a similar extent with both wild-type GST-p97 and
he three GST-tagged mutant variants (Fig. S2A,B); however, the
ifferent GST-tagged p97 proteins only partially pulled down the
BXD9. Second, we investigated the interactions of human p97
ith human UBXD9. In pull-down experiments with recombinant
roteins using GST-UBXD9 with human p97WT, p97R155C, p97R155H
nd p97R93C, we found that also human p97 and UBXD9 interacted
irectly (Fig. 3D). In control pull-downs, GST did not interact with
97. In the vice versa experiment using human GST-tagged p97WT,
97R155C, p97R155H and p97R93C proteins, UBXD9 was  very efﬁ-
iently pulled down into the pellet fraction, whereas in the control
BXD9 did not interact with GST (Fig. S2C). In conclusion, Dic-
yostelium as well as human p97 interacted directly with the UBXD9
rthologues.ain an N-terminal transmembrane domain.
in structure, see Fig. 3B.
3.4. Wild-type and mutant p97 exhibit differential and
species-speciﬁc interaction with UBXD9
To address the binding of p97 to UBXD9 quantitatively, we
performed binding assays using the surface plasmon resonance
technique. Stepwise increasing concentrations of wild-type or
mutant p97 were applied onto a CM5 chip coated with Dic-
tyostelium or human UBXD9 (Fig. S3). Binding characteristics of
the proteins in the ﬂow cells were monitored and the dissociation
constants (kd) were calculated. For Dictyostelium we  obtained
dissociation constants for the E219K and R154C/E219K mutations
that were in the same range as for wild-type p97. In contrast,
p97R154C exhibited a two-fold increase in the kd value in com-
parison to wild-type p97 (22 vs. 11 nM) (Fig. 4A, black bars).
For the orthologous R155C mutation in human p97 the opposite
effect was  detected with an approximately two-fold decrease
in the kd value (2.9 vs. 1.6 nM). We  observed no change in the
kd value of the R155H mutation, while the R93C mutation led
to an approximately two-fold increase (Fig. 4B, black bars). In
agreement with our pull-down assays, we also found that the
interactions of human p97 variants with UBXD9 were generally
much stronger, i.e., signiﬁcantly lower kd values, than the inter-
actions between Dictyostelium p97 variants and UBXD9. While
these assays were performed in the absence of ATP, we also
conducted all binding assays in the presence of the
non-hydrolysable ATP analogue AMP-PNP (adenosine 5′-(,-
imido)triphosphate) (Fig. 4, grey bars). For Dictyostelium all
AMP-PNP loaded p97 variants showed higher binding afﬁnities
in comparison to the absence of ATP. Moreover, the kd values
of the point mutated p97 variants did no longer differ from
wild-type p97. In contrast, AMP-PNP loading of human p97 did
not change the dissociation constants for wild-type, R155C, and
R155H p97, but increased the kd value for R93C p97. These results
highlighted considerable differences in the interaction properties
of Dictyostelium and human p97 variants with UBXD9. Moreover,
they revealed major inﬂuences of the p97 missense mutations
R154C/R155C and R93C on the interaction with UBXD9.
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Fig. 4. Quantitation of the p97–UBXD9 interactions by surface plasmon resonance.
A. Dissociation constant (kd) values in nM of D. discoideum wild-type and mutant
p97 binding to UBXD9 in the absence (black bars) or presence (grey bars) of the non-
hydrolysable ATP analogue AMP-PNP. B. Dissociation constants of H. sapiens wild-
type  and mutant p97 binding to UBXD9 in the absence (black bars) or presence (grey
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xperiments; p-values were calculated by Student’s t-test.
.5. Subcellular localization of Dictyostelium UBXD9 and
ild-type and mutant p97
Confocal imaging showed that in wild-type Dictyostelium cells
ndogenous p97, which was detected with the previously described
abbit polyclonal p97 antibody p97 8 6841 (Arhzaouy et al., 2012),
as distributed throughout the cytoplasm. The distribution of
ndogenous UBXD9 was analysed with the newly generated rab-
it polyclonal antibody UBX23520. UBXD9 was strongly visible in
oth the nucleus and in the cytoplasm (Fig. 5A). To further investi-
ate the subcellular localization of p97 and UBXD9 in Dictyostelium,
e generated AX2 strains ectopically expressing either wild-type
r mutant p97 fused to RFP as well as strains expressing UBXD9
used to GFP at its N- or C-terminus (Fig. S4). We  found that over-
xpressed UBXD9-GFP or GFP-UBXD9 was strongly enriched in the
ucleus with some additional diffuse cytoplasmic localization. The
resence of the GFP-tagged UBXD9 noticeably changed the sub-
ellular localization of the endogenous p97 and re-distributed it
nto the nucleus (Fig. 5B). Similarly, in cells over-expressing wild-
ype p97 fused to RFP part of the fusion protein re-localized to thell Biology 95 (2016) 195–207
nucleus and co-localized with endogenous UBXD9 preferentially in
large patches in the nuclear periphery (Fig. 5B). To investigate the
effects of the Dictyostelium p97 missense mutations, the localiza-
tions of RFP-tagged R154C, E219K, and R154C/E219K p97 mutants
and endogenous UBXD9 were analysed. Here we found no obvious
changes in the localization as compared to cells over-expressing
wild-type p97-RFP (Fig. 5C).
3.6. Normal and altered disassembly of p97 hexamers by UBXD9:
a matter of wild-type and mutant p97
To analyse molecular effects of the UBXD9–p97 interaction,
both interaction partners were incubated with the respective Dic-
tyostelium or human wild-type and mutant p97 proteins followed
by sucrose gradient sedimentation. We  found that Dictyostelium
and human wild-type and mutant p97 hexamers were present
in fractions 11–15 of higher sucrose density, while the UBXD9
proteins were enriched in fractions 3–5 of lower sucrose density
(Fig. 6A,B). Incubation of either Dictyostelium or human UBXD9 with
p97 caused a disassembly of p97 hexamers as seen by a shift of
the p97 signal into fractions 5–7. Incubation of UBXD9 with p97
mutants resulted in a signiﬁcantly reduced disassembly of p97
hexamers for all mutant proteins in both species (Fig. 6A,B). A
quantitation of the Coomassie stained p97 signal intensities of frac-
tions 5–7 and 11–15 showed that the disassembly of mutant p97
variants was  approximately half as efﬁcient as that of wild-type
p97 (Fig. 6C). In this setting, the disassembly activity of UBXD9 is
similarly affected by the orthologous R154C/R155C p97 missense
mutations.
4. Discussion
The goal of the present study was the identiﬁcation of novel Dic-
tyostelium p97 interaction partners and the comparative analysis of
Dictyostelium and human wild-type and mutant p97 variants with
respect to their biochemical properties. In a ﬁrst step, we performed
in silico analyses to generate a complete structural model of human
p97. This model was then used as a template for the calculation
of a homology model for Dictyostelium p97. With these models,
we demonstrated that the investigated mutated amino acids are
located at the surface of p97, which makes them accessible for
protein interactions (Fig. 1D).
In a second step, we compared the ATPase activities of human
and Dictyostelium wild-type and mutant p97. For human p97 we
chose the three disease causing mutations R155C, R155H, and
R93C. For Dictyostelium p97 we  investigated the orthologous R154C
mutation and included an ATPase defective E219K mutant as well
as the double mutant for these two amino acids. Previous stud-
ies had demonstrated that the second ATPase domain is crucial
for p97 function (Esaki and Ogura, 2010) and exerts the major
enzyme activity (Dalal et al., 2004; Song et al., 2003). More recently,
a study using p97 mutants defective in ATP binding in the D1 or D2
domains revealed that also the ﬁrst ATPase domain has signiﬁcant
ATPase activity which appeared to be regulated by ATP binding
in the second domain (Chou et al., 2014). Regarding the effects of
p97 disease causing mutations on its ATPase activity our litera-
ture survey revealed divergent results. For the R93C mutation, a
1.4-fold increased ATPase activity was reported (Niwa et al., 2012).
While two  studies on the R155H mutant reported ATPase activities
similar to the wild-type enzyme (Fernandez-Saiz and Buchberger,
2010; Weihl et al., 2006), four other studies reported 1.3–3-foldZhang et al., 2015). For the R155C mutant, two studies described
1.3–2.2-fold increases of the p97 ATPase activity (Manno et al.,
2010; Niwa et al., 2012). Furthermore, one study reported a 3-
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Fig. 5. Subcellular localization of Dictyostelium p97 and UBXD9.
A.  Cytosolic localization of endogenous p97 in vegetative Dictyostelium wild-type AX2 cells (ﬁrst row). Endogenous UBXD9 is localized to the cytosol and the nuclear periphery
(second row, arrows). B. Re-localisation of the endogenous p97 into the nuclei of vegetative AX2 cells ectopically expressing UBXD9-GFP or GFP-UBXD9 (ﬁrst and second
rows).  Ectopically expressed p97WT-RFP was enriched in the nucleus and co-localized with endogenous UBXD9 (third row). Detection of p97 with rabbit polyclonal antibody
p97  8 6841 (Arhzaouy et al., 2012). C. Localization of UBXD9 and p97 in vegetative cells ectopically expressing p97R154C-RFP, p97E219K-RFP, and p97R154C/E219K-RFP. Detection
of  UBXD9 was  done with rabbit polyclonal antibody UBX23520. Scale bars, 5 m;  single confocal planes of focus are shown.
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Fig. 6. Density gradient analyses of Dictyostelium and human wild-type and mutant p97 in the absence and presence of UBXD9.
A.  Sucrose gradient centrifugation of recombinant Dictyostelium wild-type and mutant p97 in the absence and presence of UBXD9. Recombinant UBXD9 promoted disassembly
of  wild-type and mutant p97 hexamers (fractions 11–15) into monomers (fractions 5–7). Recombinant wild-type and R154C, E219K, and R154C/E219K mutant p97 proteins
were  pre-incubated with UBXD9 and fractionated by sucrose density gradients (0.3 M to 1.1 M). Fractions were subjected to 10% SDS-PAGE and Coomassie staining. UBXD9
alone  was  present in fractions 3–7. B. Sucrose gradient centrifugation of human wild-type and mutant p97 in the absence and presence of UBXD9 as described in (A). C.
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ignal  intensities of monomeric p97 divided by the corresponding signal intensities
eviation of 3 independent experiments for Dictyostelium and 2–3 for human; p-va
old increased ATPase activity for the R155P p97 mutant (Halawani
t al., 2009). These studies applied different types of colorimetric
ssays in solution for the determination of the p97 ATPase activ-
ty using either recombinant bacterial His6-p97 (Dalal et al., 2004;
ernandez-Saiz and Buchberger, 2010; Lau et al., 2015; Song et al.,
003; Weihl et al., 2006; Zhang et al., 2015), p97-His6 (Chou et al.,
014; Halawani et al., 2009; Niwa et al., 2012; Tang and Xia, 2013),
yc-p97 (DeLaBarre et al., 2006), or recombinant p97-GFP puri-
ed from FreeStyle 293-F cells (Manno et al., 2010). In one case, aation of mutant p97 and UBXD9 shown in (A) and (B). Bars indicate the ratios of the
xameric p97 with the wild-type ratio scaled to 1; error bars represent the standard
ere calculated by Student’s t-test.
luminescence based ATPase assay in solution was described using
recombinant His6-p97 (Chou et al., 2011).
To address putative changes of the ATPase activities, we used
clear-native gels (CN-PAGE) in conjunction with an in-gel ATPase
assay. This technique, which was originally described for native p97
puriﬁed from red blood cells (Harris, 1984; Peters et al., 1992; White
and Ralston, 1976) and later further developed and used for mito-
chondrial complex V ATPase stains (Wittig et al., 2007; Zerbetto
et al., 1997), has the unique advantage to stain speciﬁc protein
bands and protein complexes. Thus, this approach excludes any bias
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y p97 degradation products or other protein contaminations. For
xample, recombinant p97 from bacteria is usually contaminated
ith varying amounts of the chaperone and ATPase DnaK (Hsp70)
personal observation). In this context, it is noteworthy that two
ecent studies showed that Hsc70, another chaperone, has signif-
cant ATPase activity as compared to p97 (Kang et al., 2014; Lau
t al., 2015).
Our gel-based p97 ATPase assays demonstrated that wild-type
ictyostelium p97 possesses four times the activity of human p97.
examers of mutant human R155C, R155H, and R93C p97 exhibited
n approximately 4-fold higher ATPase activity than the wild-type
rotein. The ATPase activity, which we observed at the migrating
osition of p97R155C monomers, may  either result from enzymatic
ctive p97 monomers or from spurious amounts of p97 hexamers
hat may  have re-assembled from monomers after CN-PAGE sepa-
ation. In contrast, the Dictyostelium R154C p97 hexamers did not
isplay any increase in their ATPase activity highlighting species-
ependent differences. The E219K mutation of Dictyostelium p97,
hich is located close to the N-terminus of D1, nearly abolished the
97 catalytic activity, which was partially rescued by the second
utation in the R154C/E219K double-mutant (Fig. 2). The latter
ffect suggests an inter-domain communication involving the N-
nd both D-domains of p97. This hypothesis is supported by studies
hat demonstrated effects of the N-domain on the intrinsic ATPase
ctivity (Fernandez-Saiz and Buchberger, 2010; Gerega et al., 2005;
alawani et al., 2009; Weihl et al., 2006) and a further report that
evealed a signiﬁcant ATPase activity of the p97 D1 ATPase domain
Chou et al., 2014). Based on these results, regulatory interactions
etween the N-, D1- and D2- domains were proposed, which are
rucial for the p97 enzyme functions. This notion is further substan-
iated by a new study that observed substantial structural changes
f the D2 ATPase domain induced by the disease-causing R155P
97 mutation (Mountassif et al., 2016).
Our search for novel p97 binding partners led to the identiﬁca-
ion of the UBL and UBX domain containing Dictyostelium protein
BXD9 (Table 1). UBX-domain containing proteins contribute the
argest known family of p97 binding proteins (Kloppsteck et al.,
012; Meyer and Weihl, 2014; Raman et al., 2015; Schuberth and
uchberger, 2008). UBXD9 proteins constitute a subfamily, which
s characterized by the additional presence of an N-terminal UBL
omain (Schauber et al., 1998) and a coiled-coil domain preced-
ng the C-terminal UBX domain (Fig. 3B). Our immunoﬂuorescence
nalysis showed a cytoplasmic and nuclear localization of Dic-
yostelium UBXD9 and revealed nuclear enrichment of p97 in cells
ver-expressing UBXD9. A corresponding cytoplasmic and nuclear
ocalization has previously been reported for human UBXD9 and
ts over-expression likewise caused accumulation of p97 in the
ucleus (Orme and Bogan, 2012). We  found that for mutant Dic-
yostelium p97 this UXBD9-mediated nuclear localization was not
ltered.
Although our in vitro UBXD9–p97 binding studies revealed
pecies-speciﬁc differences in the UBXD9 interactions with
ictyostelium and human p97, both protein species similarly dis-
ssembled p97 hexamers. A study on the UBX-domain containing
omolog PUX1 in Arabidopsis thaliana previously had revealed its
isassembling activity on p97 hexamers (Rancour et al., 2004),
nd also human UBXD9 was reported to exert a p97 monomerisa-
ion activity (Orme and Bogan, 2012). We  show that Dictyostelium
154C and the orthologous human R155C p97 mutant display a
arkedly decreased sensitivity to UBXD9-mediated monomerisa-
ion of p97 hexamers. The other p97 mutations of Dictyostelium,
219K and R154C/E219K, and of human, R93C and R155H, also
aused a decreased sensitivity to UBXD9-mediated monomeri-
ation. It seems unlikely that UBXD9 interacts with p97 at all
hese positions of mutant amino acids. Thus, as discussed for the
TPase activity, mutation-induced inter-domain communicationll Biology 95 (2016) 195–207 205
changes in p97 may  also be responsible for its partial resistance to
monomerisation. Since both the UBL (Schauber et al., 1998; Su and
Lau, 2009) and UBX (Schuberth and Buchberger, 2008) domain con-
taining proteins are involved in the protein quality control systems,
it is tempting to speculate that changes in the hexamer-monomer
equilibrium of missense mutated p97 contribute to the p97 disease
pathology.
Irrespective of a very high degree of p97 sequence conserva-
tion, our work highlights essential differences in the biochemical
properties of Dictyostelium and human p97 orthologues. Thus, func-
tional data of non-human p97 do not necessarily mirror the human
situation and should be interpreted with caution. We  demon-
strate that human disease-causing p97 point mutations result in
an increased ATPase activity. Moreover, they interfere with the
UBXD9-mediated p97 hexamer-monomer equilibrium. As p97 and
UBXD9 only co-localize to a limited extent, UBXD9 may  locally
regulate the function of p97. Further studies have to address the
question whether the late-onset p97 human disease pathology is
related to an increased ATPase activity and/or altered UBXD9 pro-
tein interactions.
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